EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY-NC 4.0

Dupilumab's Successful Journey in Pityriasis Lichenoides Chronica Followed by the Intriguing Reemergence of Vitiligo After Monobenzone Depigmentation: A Case Report

Khalid Nabil Nagshabandi, Mohammed Aljughayman, Asem Shadid, Salman Almalki, Nouf Almuhanna

Case Reports in Dermatology · 15.05.2025 · 1-12

DOI: 10.1159/000545212 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Case Reports in Dermatology, online erschienen am 15.05.2025. Verfasst von Khalid Nabil Nagshabandi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, College of Medicine, King Saud University, Riyadh, Saudi Arabia. Die Arbeit wurde bisher 4-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Pityriasis lichenoides (PL), comprising acute (PLEVA) and chronic (PLC) subtypes, represents a spectrum of inflammatory skin conditions with overlapping clinical and histopathological features. Standard treatments include oral antibiotics, phototherapy, and immunosuppressive agents. Dupilumab, an IL-4Rα antagonist, is approved for atopic dermatitis and used off-label for other inflammatory skin conditions but has limited documentation in PL treatment.

Objective

To report a novel case of successful PLC management with dupilumab and an unexpected reemergence of skin pigmentation following prior monobenzone depigmentation therapy for vitiligo.

Methods

A 40-year-old female with a history of extensive vitiligo and monobenzone depigmentation therapy presented with scaly, erythematous plaques and severe pruritus. Skin biopsy confirmed PLC. Conventional treatments were declined due to concerns about pigmentation changes. Dupilumab was initiated at a loading dose of 600 mg, followed by 300 mg biweekly.

Results

After three months of dupilumab therapy, significant improvement in PLC lesions and pruritus was observed, with only residual erythematous plaques. Remarkably, skin repigmentation occurred spontaneously, contrasting with previously reported cases of vitiligo exacerbation following dupilumab use. Depigmentation therapy with monobenzone was resumed without exacerbating PLC or pruritus.

Conclusion

This case highlights dupilumab's potential as an effective treatment for PLC and its intriguing role in promoting skin repigmentation in a patient with prior vitiligo. These findings suggest a possible link between type 2 inflammation and PLC pathogenesis, warranting further investigation. Dupilumab could serve as a promising therapeutic alternative for refractory PLC. Keywords: Biologics - Case report - Depigmentation - Dupilumab - Pityriasis Lichenoides Chronica - Pityriasis Lichenoides et Varioliformis Acuta - PLC - Vitiligo

Schlagwörter

Stichwörter der Autor:innen

BiologicsCase reportDepigmentationDupilumabPityriasis lichenoides chronicaPityriasis lichenoides et varioliformis acutaVitiligo

Autor:innen und Institutionen

  • Department of Dermatology, College of Medicine, King Saud University, Riyadh, Saudi Arabia.
  • Department of Dermatology, King Fahad Medical City, Riyadh, Saudi Arabia.
  • Department of Pathology, King Fahad Medical City, Riyadh, Saudi Arabia.

Zitieren

APA

Nagshabandi, K. N., Aljughayman, M., Shadid, A., Almalki, S., & Almuhanna, N. (2025). Dupilumab's Successful Journey in Pityriasis Lichenoides Chronica Followed by the Intriguing Reemergence of Vitiligo After Monobenzone Depigmentation: A Case Report. Case Reports in Dermatology, 1-12. https://doi.org/10.1159/000545212

Vancouver

Nagshabandi KN, Aljughayman M, Shadid A, Almalki S, Almuhanna N. Dupilumab's Successful Journey in Pityriasis Lichenoides Chronica Followed by the Intriguing Reemergence of Vitiligo After Monobenzone Depigmentation: A Case Report. Case Reports in Dermatology. 2025:1-12. doi:10.1159/000545212

BibTeX
@article{Nagshabandi2025,
  author = {Nagshabandi, Khalid Nabil and Aljughayman, Mohammed and Shadid, Asem and Almalki, Salman and Almuhanna, Nouf},
  title = {Dupilumab's Successful Journey in Pityriasis Lichenoides Chronica Followed by the Intriguing Reemergence of Vitiligo After Monobenzone Depigmentation: A Case Report},
  journal = {Case Reports in Dermatology},
  year = {2025},
  pages = {1--12},
  doi = {10.1159/000545212}
}
Kostenlos starten →